Todd Villines: Coronary Artery Disease – A BIG Movement to Change
Dr. Todd C. Villines, Professor of Cardiology and Vice-Chief of CV Division at the University of Virginia (UVA), posted on X:
”Coronary artery disease: a BIG movement to change from reactive end-stage treatment to early detection and treatment.
Kudos to the The Lancet Commission for actively studying the global health benefits of this paradigm shift from “ischemic” heart disease to atherosclerosis.”
Read the editorial here.
Read the full article here.
Title: The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Authors: Sarah Zaman, Jason H Wasfy, Vikas Kapil, Boback Ziaeian, William A Parsonage, Sira Sriswasdi, Timothy J A Chico, Davide Capodanno, Róisín Colleran, Nadia R Sutton, Lei Song, Nicole Karam, Reecha Sofat, Chiara Fraccaro, Daniel Chamié, Mirvat Alasnag, Takayuki Warisawa, Nieves Gonzalo, Walid Jomaa, Shamir R Mehta, Elizabeth E S Cook, Johan Sundström, Stephen J Nicholls, Leslee J Shaw, Manesh R Patel, Rasha K Al- Lamee
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show